| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,273 | 39,416 | 39,689 | 40,571 | | Cost of Revenue | 9,450 | 9,465 | 9,786 | 9,083 | | | Gross Profit | 30,823 | 29,951 | 29,903 | 31,488 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,259 | 3,280 | 2,789 | 3,417 | | Non Recurring | 189 | 559 |
-
|
-
| | Others | 7,084 | 6,756 | 7,368 | 7,817 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,629) | 19,356 | 19,746 | 20,254 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,660) |
-
| 1,096 | | Earnings Before Interest And Taxes | (965) | 14,692 | 19,746 | 13,378 | | Interest Expense | 8,942 | 8,782 | 8,196 | 8,401 | | Income Before Tax | (9,907) | 5,910 | 11,550 | 4,977 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (1,742) | (3,004) |
-
| (2,135) | | | | Net Income From Continuing Ops | (16,313) | 5,910 | 11,550 | 10,814 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,607 | 5,910 | 11,550 | 10,814 | | Preferred Stock And Other Adjustments | (3,785) | (1,976) | (5,594) | (3,785) | | | Net Income Applicable To Common Shares | $5,822 | $3,934 | $5,956 | $7,029 |
|
0.31% Nasdaq 
0.05%
Income Statement
